The regulatory route question for lithium orotate
Lithium orotate is bought against a specification, but the specification does not answer the question a regulatory reviewer will ask first: may this material be sold as a food or supplement ingredient in the destination market, or does it fall under a different set of rules? Lithium is regulated differently from an ordinary mineral in many markets, and the answer depends on the market, the finished product and the presentation. This page sets out the documents and checks the file needs; it does not state a status for any market.
The specification describes the salt; whether lithium may be sold as a food or supplement ingredient is a question about the destination and the presentation, and the buyer's regulatory team answers it.
Four questions, and the route is one of them
A complete file answers four questions in order. What exactly is being bought, and against which revision of the specification? Which lot is in the drum, and what did its certificate measure? Which route applies to the finished product in the destination? And which parts must be re-qualified when the source, the process or the pack shifts? The lot is covered by the certificate, the specification by the technical data sheet, handling by the safety data sheet. None of the three covers the route.
For most mineral salts the route question is settled by the permitted-ingredient list of the destination. For lithium it is not that simple, because the same element appears in more than one regulatory category across markets. The file should record the route the buyer's team has confirmed, in writing, with the date and the version it relied on. A route that lives only in an email chain is not a document.
European Union and the United Kingdom
The EU file starts with Regulation (EC) No 178/2002 on general food law, Directive 2002/46/EC on food supplements and Regulation (EU) No 1169/2011 on food information, and adds any product-specific route. The reviewer checks whether the mineral appears in the permitted list for the destination, whether an authorisation under Regulation (EU) 2015/2283 is engaged, and whether the member state regards the presentation as a medicinal product. Those are three separate questions, and a positive answer to one does not settle the others.
The contaminant results are read against Regulation (EU) 2023/915 as it stands, and the label against the food-information rules. Great Britain is checked separately from Northern Ireland: the GB file uses the current GB rules and lists, and Northern Ireland follows the EU framework. A file built for one of the two is not automatically valid for the other, and the order documents should say which one was reviewed.
United States
The US file is built around the dietary-supplement framework: the ingredient, its intended use, the manufacturing rules in 21 CFR 111 and the labelling rules in 21 CFR 101.36. Where the ingredient was not marketed in the United States before the statutory cut-off, a notification under 21 U.S.C. 350b may be part of the route; whether one is needed, and whether the supporting safety file is adequate, is a determination for the buyer's regulatory team and the agency.
There is a second layer in the US that matters for this material. As of this review, a lithium salt is the active substance of a prescription medicine there, so a supplement presentation is reviewed against the rules that keep a drug and a supplement apart as well as against the supplement rules. That is exactly why we do not describe a status: it depends on the presentation, the claims and the destination, and it can change.
Limits that depend on the dose
Contaminants have to be worked out on the finished product, not only on the drum. The catalog limits below are the ingredient gate; the destination text and the daily dose decide what the finished product may contain, and the calculation has to be shown in the file.
| Parameter | Catalog limit | What the file should show |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Lot result, method and the finished-product calculation |
| Arsenic (As) | ≤2 mg/kg | Lot result and the agreed limit for the destination |
| Cadmium (Cd) | ≤1 mg/kg | Lot result and any category exception that applies |
| Mercury (Hg) | ≤0.1 mg/kg | Lot result and method |
Because the salt is only 4.28% lithium, the heavy-metal intake from the ingredient scales with the powder mass, not with the lithium figure, which matters in the finished-product arithmetic. Whether any maximum applies to the element itself is a destination question, and it belongs in the same written record as the route.
Claims and the label
The label names the ingredient in the form the destination requires, declares the quantity, and carries only wording the brand's reviewer has cleared. A certificate is not an approval of a claim, and a claim cannot amend a specification. For this material the claim review is unusual, because a wording that would be a structure or function statement for a nutrient may be read differently when the same substance is a medicine in that market.
We make no disease-related claim for this product, and this page is not a label or a claim of any kind. The buyer's regulatory team confirms the permitted wording, the permitted dose and the permitted population for the destination before the artwork is signed off.
Documents in the file
The technical set is the specification, a certificate per lot, the technical data sheet and the safety data sheet. Beside it sit the statements the importer needs: allergen, GMO, origin, residual solvents and any customer-specific declaration. The heavy-metal and microbiology results belong with the lot, not in a separate folder that cannot be matched to a pack.
The regulatory set is the destination route confirmation, the label and claim review, and the change-control record for the source, the process and the pack. When a statement is not available for a lot, the gap should be named before the order rather than found at the port. Keep a list with versions and dates; a folder of undated PDFs is not a file.
Checklist before the first order
- The specification revision, the CAS number and the word anhydrous all appear on the order.
- The destination route is confirmed in writing by the buyer's regulatory team.
- The document set — certificate, specification, safety data sheet, allergen, GMO, origin, residual solvents — is complete and dated.
- Heavy-metal results are converted to the finished-product dose and checked against the destination text.
- Artwork and wording are cleared for the destination and for the population named on the pack.
- Source, process and pack are under change control, and the quotation cites the same specification version.
The catalog figures are on the lithium orotate product page; the lot certificate is explained on the COA page; the analytical evidence is on the identity page; the salt comparison is on the orotate versus carbonate page; the framework references are in the EU regulatory notes; the release file is described on the quality page. The magnesium orotate file is a useful parallel, because the same acid carries a much more ordinary route question there.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation